Dr. Eliana Lacerda has focused her research activities on clinical and epidemiological aspects of ME/CFS, since 2007, and co-founded the CureME team at the London School of Hygiene & Tropical Medicine (London, UK). Additionally, Dr. Lacerda co-created the UK ME/CFS Biobank (UKMEB), the first disease-specific biobank dedicated to ME/CFS research, of which she is the Clinical Director. The UKMEB, have provided biosamples and data to research groups at universities around the world, including in the UK (Cambridge, Oxford, University College London, Dundee, Surrey, and Cardiff); Brazil (University of São Paulo); Spain (Universidad Católica de Valencia); Israel (Weizmann Institute of Science), Austria (Institute of Biomedical Science, Graz), Germany (Charité), the US (The Jackson Laboratory, UMass Amherst, Whittemore Peterson Institute, Stanford University), and Australia (Garvan-Weizmann Centre for Cellular Genomics).
Dr. Eliana Lacerda has been the Vice-Chair of EUROMENE, a network involving participants from 22 European countries, which provided guidelines for epidemiological, clinical and biomarkers research, in addition to diagnosis of and health care provision to people with ME/CFS. Dr. Lacerda is the PI for a new research project (NIH funded) on HHV6 viral reactivation in people with ME/CFS and with Long Covid in the UK.